Assured Pharmacy, Inc. (Pink Sheets: APHY), announced today that due to numerous inquiries, the Company would like to provide further clarification on the Confidential Treatment ("CT") Order filing dated March 10, 2009. The CT Order filing that appears in the Company's public filings available at www.sec.gov is an order of the SEC granting the Company's previous request for confidential treatment of certain information that was omitted from a prime vendor agreement that the Company entered into with AmerisourceBergen Drug Corporation, a Delaware corporation, which was filed as an exhibit to the Form 8-K filed on October 9, 2008. The 8-K filing is accessible from the following link:
http://www.sec.gov/Archives/edgar/data/1100592/000093041308005953/c55223_8k.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment